Patent ID: 11918633
Assignee: BIOMARIN PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 1:
2. The method of claim 1, wherein
a. the weekly dose is administered for more than 60 weeks, more than 70 weeks, more than 80 weeks, more than 90 weeks, more than 100 weeks, more than 110 weeks, more than 120 weeks, more than 130 weeks, more than 140 weeks, more than 150 weeks, more than 160 weeks, more than 170 weeks, more than 180 weeks, more than 190 weeks, more than 200 weeks, more than 210 weeks, more than 220 weeks, more than 230 weeks, more than 240 weeks, or more than 250 weeks; and/or
b. the dosage is in the range of about 0.1 mg per week to about 1 mg per week, about 1 mg per week to about 2 mg per week, about 2 mg per week to about 10 mg per week, about 10 mg per week to about 20 mg per week, about 20 mg per week to about 40 mg per week, about 40 mg per week to about 70 mg per week, about 70 mg per week to about 140 mg per week, about 140 mg per week to about 280 mg per week, about 280 mg per week to about 420 mg per week, or about 420 mg per week to about 840 mg per week.